MedTrace Logo

Mobile Enhanced Prevention Support for People Leaving Jail

NCT04036396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2026-05-20

Study results available
· View outcomes & findings →

Summary

This study will provide HIV prevention and related support services to men who have sex with men and transgender women who have substance use disorders and are either leaving jail or recently released from jail. The researchers will compare the utilization of HIV prevention and other support services between individuals who receive routine case management provided following enrollment to those who have access to GeoPassport, a global position service (GPS)-based mobile app, incentives, and peer mentor support.

Conditions

Interventions

BEHAVIORAL

Mobile Enhanced Prevention Support

Access to the newly developed GeoPassport App, incentives for accessing identified services, and a trained Peer Mentor.

BEHAVIORAL

Usual Care plus Customized Referrals

Participants in the control arm will continue to receive services they would normally receive consistent with the setting in which they were recruited. This includes substance use treatment in jail, substance use treatment at a residential recovery facility, and/or supportive housing services. The study will provide referrals customized to their needs and preferences.

Sponsors & Collaborators

  • Los Angeles Centers For Alcohol and Drug Abuse

    collaborator UNKNOWN

  • Charles Drew University of Medicine and Science

    collaborator OTHER

  • California HIV/AIDS Research Program

    collaborator OTHER

  • Friends Research Institute, Inc.

    collaborator OTHER

  • University of California, Los Angeles

    lead OTHER

Principal Investigators

  • Nina T Harawa, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-14
Primary Completion
2024-01-11
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04036396 on ClinicalTrials.gov